Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Atomo Diagnostics Ltd. ( (AU:AT1) ).
Atomo Diagnostics Ltd. has announced the quotation of 2,000,000 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code AT1, effective July 9, 2025. This move is part of previously announced transactions and is expected to enhance the company’s capital structure, potentially impacting its market positioning and providing additional resources for its operations.
More about Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd. operates in the medical diagnostics industry, focusing on the development and commercialization of innovative rapid diagnostic test devices. The company is known for its user-friendly, integrated testing solutions that aim to improve healthcare accessibility and outcomes.
Average Trading Volume: 624,719
Technical Sentiment Signal: Sell
Current Market Cap: A$10.76M
See more data about AT1 stock on TipRanks’ Stock Analysis page.